Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Bio-Protocol|January 10, 2022
A Simple Method for in situ Quantification of Cells on CarriersOsnat Rosen, Avital Jayson, Niva Natan, et al.Biotechnology and Bioengineering|June 10, 2021
Novel method for quantifying cells on carriers and its demonstration during SARS-2 vaccine developmentOsnat Rosen, Avital Jayson, Niva Natan, et al.Journal of Tissue Engineering and Regenerative Medicine|November 22, 2021
Poly(vinyl alcohol)-methacrylate with CRGD peptide: A photocurable biocompatible hydrogelMichael Goldvaser, Eyal Epstein, Osnat Rosen, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's diseaseAbraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.Biotechnology and Bioengineering|March 23, 2022
Optimization of VSV-ΔG-spike production process with the Ambr15 system for a SARS-COV-2 vaccineOsnat Rosen, Avital Jayson, Michael Goldvaser, et al.Biotechnology Progress|May 28, 2022
Application of Ambr15 system for simulation of entire SARS-CoV-2 vaccine production process involving macrocarriersAvital Jayson, Michael Goldvaser, Eyal Dor, et al.Journal of Molecular Neuroscience : MN|September 23, 2003
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapyAbraham Fisher, Zipora Pittel, Rachel Haring, et al.Molecules (Basel, Switzerland)|June 2, 2021
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug LibrariesAlon Ben David, Eran Diamant, Eyal Dor, et al.Neuro-Degenerative Diseases|November 26, 2015
AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s DiseaseAbraham Fisher, Ilya Bezprozvanny, Lili Wu, et al.Vaccines|April 27, 2024
Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2Einat Toister, Lilach Cherry, Edith Lupu, et al.Pageof 2